Alkermes (ALKS) EBT (2010 - 2026)
Alkermes (ALKS) posted EBT of -$1.88 million for Q2 2026, compared with $104.84 million a year earlier.
Powered by 
Analysis
Alkermes (ALKS) EBT (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT at Alkermes was $97.32 million, down 76.3% year-over-year; for FY2025, it was $291.45 million, down 34.3% from FY2024.
- In prior years, Alkermes' EBT was $443.75 million in FY2024 (+5.3%), $421.52 million in FY2023, -$31.13 million in FY2022 and $87.73 million in FY2021.
- Quarterly EBT has run from a low of -$67.37 million in Q3 2022 to a high of $281.83 million in Q2 2023 over five years.
- On a year-over-year basis, EBT increased in two of the last six quarters, with growth averaging 13.6%.
- The strongest year-over-year quarter for EBT in the past five years was Q4 2024, with growth of 191.3%; the weakest was Q4 2025, with a decline of 64.5%.
- According to Business Quant data, EBT for the three prior quarters was -$61.93 million (Q1 2026), $60.38 million (Q4 2025) and $100.75 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.39 Bn |
| 10 | Alkermes | 6.79 Bn | 3.92 Bn | 397.90 Mn | -1.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.88 Mn |
| Mar 31, 2026 | -61.93 Mn |
| Dec 31, 2025 | 60.38 Mn |
| Sep 30, 2025 | 100.75 Mn |
| Jun 30, 2025 | 104.84 Mn |
| Mar 31, 2025 | 25.49 Mn |
| Dec 31, 2024 | 169.89 Mn |
| Sep 30, 2024 | 110.23 Mn |
| Jun 30, 2024 | 116.72 Mn |
| Mar 31, 2024 | 46.91 Mn |
| Dec 31, 2023 | 58.32 Mn |
| Sep 30, 2023 | 92.71 Mn |
| Jun 30, 2023 | 281.83 Mn |
| Mar 31, 2023 | -11.33 Mn |
| Dec 31, 2022 | 114.49 Mn |
| Sep 30, 2022 | -67.37 Mn |
| Jun 30, 2022 | -33.25 Mn |
| Mar 31, 2022 | -45.00 Mn |
| Dec 31, 2021 | 127.26 Mn |
| Sep 30, 2021 | -26.54 Mn |
API Access
Alkermes EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();